Table 3 Completed cases and reasons of discontinuation
From: Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies
| Â | BNS01 study | BNS02 study |
|---|---|---|
N = 321 | N = 61 | |
Dose of BNS | ||
 Mean final dose [SD] (mg/day) | 13.0 [6.7] | 12.8 [6.1] |
 Mean maximum dose [SD] (mg/day) | 14.8 [7.2] | 14.0 [6.1] |
Completed cases | ||
 Week 28 completed, n (%) | 264 (82.2) | 48 (78.7) |
 Weeks 28–52 completed, n (%) | 93 (29.0) | 3 (4.9%) |
 Weeks 52–56 completed, n (%) | 155 (48.3) | 38 (62.3) |
 Mean treatment duration [SD] (day) | 268.2 [123.2] | 301.9 [126.5] |
Concomitant use | ||
 Antipsychotic drugs | 286 (89.1) | 17 (27.9) |
 Antiparkinsonian drugs | 299 (93.1) | 55 (90.2) |